Gsa Capital Partners LLP Veru Inc. Transaction History

Gsa Capital Partners LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$4.35 - $15.85 $78,969 - $287,740	-18,154 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$4.55 - $6.41 $78,487 - $110,572	-17,250 Reduced 48.72%	18,154 $88,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $426,695 - $704,880	-72,444 Reduced 67.17%	35,404 $209,000
Q3 2021 Nov 12, 2021	BUY	$6.78 - $9.89 $731,209 - $1.07 Million	107,848 New	107,848 $920,000
Q1 2021 May 10, 2021	SELL	$8.05 - $20.78 $1.08 Million - $2.8 Million	-134,587 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$2.36 - $9.99 $260,791 - $1.1 Million	-110,505 Reduced 45.09%	134,587 $1.16 Million
Q3 2020 Nov 06, 2020	BUY	$2.58 - $3.36 $471,799 - $614,436	182,868 Added 293.89%	245,092 $642,000
Q2 2020 Aug 11, 2020	BUY	$3.01 - $4.02 $187,294 - $250,140	62,224 New	62,224 $208,000
Q2 2018 Aug 09, 2018	SELL	$1.64 - $2.29 $114,332 - $159,647	-69,715 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$1.19 - $2.17 $20,516 - $37,412	-17,241 Reduced 19.83%	69,715 $126,000
Q4 2017 Feb 14, 2018	SELL	$0.98 - $2.27 $81,009 - $187,645	-82,663 Reduced 48.73%	86,956 $99,000
Q3 2017 Nov 20, 2017	BUY	$1.2 - $2.84 $203,542 - $481,717	169,619	169,619 $449,000

122

56.6M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $50.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.